Literature DB >> 22496348

Increased MMPs expression and decreased contraction in the rat myometrium during pregnancy and in response to prolonged stretch and sex hormones.

Zongzhi Yin1, Alaa A Sada, Ossama M Reslan, Neha Narula, Raouf A Khalil.   

Abstract

Normal pregnancy is associated with uterine relaxation to accommodate the stretch imposed by the growing fetus; however, the mechanisms underlying the relationship between pregnancy-associated uterine stretch and uterine relaxation are unclear. We hypothesized that increased uterine stretch during pregnancy is associated with upregulation of matrix metalloproteinases (MMPs), which in turn cause inhibition of myometrium contraction and promote uterine relaxation. Uteri from virgin, midpregnant (day 12), and late-pregnant rats (day 19) were isolated, and myometrium strips were prepared for measurement of isometric contraction and MMP expression and activity using RT-PCR, Western blot analysis, and gelatin zymography. Oxytocin caused concentration-dependent contraction of myometrium strips that was reduced in mid- and late-pregnant rats compared with virgin rats. Pretreatment with the MMP inhibitors SB-3CT (MMP-2/MMP-9 Inhibitor IV), BB-94 (batimastat), or Ro-28-2653 (cipemastat) enhanced contraction in myometrium of pregnant rats. RT-PCR, Western blot analysis, and gelatin zymography demonstrated increased mRNA expression, protein amount, and activity of MMP-2 and MMP-9 in myometrium of late-pregnant>midpregnant>virgin rats. Prolonged stretch of myometrium strips of virgin rats under 8 g basal tension for 18 h was associated with reduced contraction and enhanced expression and activity of MMP-2 and MMP-9, which were reversed by MMP inhibitors. Concomitant treatment of stretched myometrium of virgin rats with 17β-estradiol (E2), progesterone (P4), or E2+P4 was associated with further reduction in contraction and increased MMP expression and activity. MMP-2 and MMP-9 caused significant reduction of oxytocin-induced contraction of myometrium of virgin rat. Thus, normal pregnancy is associated with reduced myometrium contraction and increased MMPs expression and activity. The results are consistent with the possibility that myometrium stretch and concomitant increase in sex hormones during pregnancy are associated with increased expression/activity of specific MMPs, which in turn inhibit uterine contraction and promote uterine relaxation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496348      PMCID: PMC3404560          DOI: 10.1152/ajpendo.00553.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  69 in total

1.  Dynamic in vivo changes in the activities of gelatinases, matrix metalloproteinases (MMPs), and tissue inhibitor of metalloproteinases (TIMPs) in buffalo (Bubalus bubalis) uterine luminal fluid during estrous cycle and early pregnancy.

Authors:  Sudhir C Roy; Jyotirmoy Ghosh
Journal:  Mol Reprod Dev       Date:  2010-09-30       Impact factor: 2.609

Review 2.  Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development.

Authors:  J Patel; K Landers; R H Mortimer; K Richard
Journal:  Placenta       Date:  2010-09-24       Impact factor: 3.481

3.  Bovine endometrial metallopeptidases MMP14 and MMP2 and the metallopeptidase inhibitor TIMP2 participate in maternal preparation of pregnancy.

Authors:  Susanne E Ulbrich; Swanhild U Meyer; Karina Zitta; Stefan Hiendleder; Fred Sinowatz; Stefan Bauersachs; Mathias Büttner; Thomas Fröhlich; Georg J Arnold; Horst-Dieter Reichenbach; Eckhard Wolf; Heinrich H D Meyer
Journal:  Mol Cell Endocrinol       Date:  2010-09-29       Impact factor: 4.102

4.  Uteroplacental insufficiency programs regional vascular dysfunction and alters arterial stiffness in female offspring.

Authors:  Marc Q Mazzuca; Mary E Wlodek; Nicoleta M Dragomir; Helena C Parkington; Marianne Tare
Journal:  J Physiol       Date:  2010-04-19       Impact factor: 5.182

5.  Trophoblast- and vascular smooth muscle cell-derived MMP-12 mediates elastolysis during uterine spiral artery remodeling.

Authors:  Lynda K Harris; Samantha D Smith; Rosemary J Keogh; Rebecca L Jones; Philip N Baker; Martin Knöfler; Judith E Cartwright; Guy St J Whitley; John D Aplin
Journal:  Am J Pathol       Date:  2010-08-27       Impact factor: 4.307

6.  Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis.

Authors:  Sachiko Matsuzaki; Elodie Maleysson; Claude Darcha
Journal:  Hum Reprod       Date:  2009-12-10       Impact factor: 6.918

7.  Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner.

Authors:  Ahmed E Awad; Vijay Kandalam; Subhadeep Chakrabarti; Xiuhua Wang; Josef M Penninger; Sandra T Davidge; Gavin Y Oudit; Zamaneh Kassiri
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-09       Impact factor: 4.249

8.  Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy.

Authors:  Katsuhiko Naruse; Gendie E Lash; Barbara A Innes; Harry A Otun; Roger F Searle; Stephen C Robson; Judith N Bulmer
Journal:  Hum Reprod       Date:  2008-12-16       Impact factor: 6.918

9.  MMP-2 induced vein relaxation via inhibition of [Ca2+]e-dependent mechanisms of venous smooth muscle contraction. Role of RGD peptides.

Authors:  Joseph D Raffetto; Yaskara V R Barros; Amanda K Wells; Raouf A Khalil
Journal:  J Surg Res       Date:  2008-10-24       Impact factor: 2.192

Review 10.  Regulation of oxygen homeostasis by hypoxia-inducible factor 1.

Authors:  Gregg L Semenza
Journal:  Physiology (Bethesda)       Date:  2009-04
View more
  26 in total

Review 1.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

Authors:  Elisabeth MacColl; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-08-28       Impact factor: 4.030

Review 2.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

3.  Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.

Authors:  Juanjuan Chen; Zongli Ren; Minglin Zhu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2017-05-12       Impact factor: 5.858

Review 4.  Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

Authors:  Juanjuan Chen; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-22       Impact factor: 3.622

5.  Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α.

Authors:  Wei Li; Ning Cui; Marc Q Mazzuca; Karina M Mata; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

6.  Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.

Authors:  Carlos A Dias-Junior; Juanjuan Chen; Ning Cui; Charles L Chiang; Minglin Zhu; Zongli Ren; Jose S Possomato-Vieira; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2017-09-11       Impact factor: 5.858

7.  Adaptive reduction of human myometrium contractile activity in response to prolonged uterine stretch during term and twin pregnancy. Role of TREK-1 channel.

Authors:  Zongzhi Yin; Wenzhu He; Yun Li; Dan Li; Hongyan Li; Yuanyuan Yang; Zhaolian Wei; Bing Shen; Xi Wang; Yunxia Cao; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-03-22       Impact factor: 5.858

8.  EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone.

Authors:  Yiping Dang; Wei Li; Victoria Tran; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2013-07-13       Impact factor: 5.858

9.  Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.

Authors:  Zongli Ren; Ning Cui; Minglin Zhu; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-03-23       Impact factor: 4.733

10.  Zymography as a Research Tool in the Study of Matrix Metalloproteinase Inhibitors.

Authors:  Zongli Ren; Juanjuan Chen; Raouf A Khalil
Journal:  Methods Mol Biol       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.